Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Nanobiotix S.A
NBTX | US
30.34
USD-0.25
-0.82%
NBTX | US
About Nanobiotix S.A
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
10/04/2026
Close
30.34
Open
30.71
High
31.00
Low
29.65
Nanobiotix S.A. a clinical-stage biotechnology focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3 a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma head and neck cancers liver cancers prostate cancer pancreatic cancer esophageal cancer rectal cancer and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China South Korea Singapore and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris France.
View LessNBTX | US
Risk
93.6
Sharpe
8.58
Luna's Score
51/100
Recommendation
Hold
Luna says (NBTX | US)
What's Working
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
93.4%1 month
93.6%3 months
96.8%6 months
109.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
48.31
Price to book
65.02
Debt to equity
-2.04
Debt to assets
0.51
Ent. to EBITDA
-2.45
Ent. to rev.
5.22
PEG
-
Other Fundamentals
EBITDA
-22.30M
MarketCap
1.45B
MarketCap(USD)
1.45B
Div. yield
-
Op. margin
-253.32
Erngs. growth
-
Rev. growth
182.10
Ret. on equity
-198.69
Short ratio
2.52
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
5.66
Range1M
8.14
Range3M
22.28
Volumes: Market Activity
Rel. volume
0.67
Price X volume
1.40M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.45 | - | Cheaper |
| Ent. to Revenue | 5.22 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 65.02 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 96.77 | - | Riskier |
| Debt to Equity | -2.04 | -1.23 | Cheaper |
| Debt to Assets | 0.51 | 0.25 | Expensive |
| Market Cap | 1.45B | - | Emerging |
